Article
High prevalence and global distribution of fosfomycin resistance genes in Salmonella serovars
2 Sept 2023
Abstract excerpt
Fosfomycin, an old antimicrobial agent with a broad spectrum of activity, has been reintroduced into clinical use for the treatment of patients with difficult-to-treat-infections,1 including those due to carbapenem-resistant Enterobacterales.2 However, fosfomycin-resistant bacterial strains (including Salmonella spp) have emerged and spread, potentially posing a crucial threat to public health3 as Salmonella spp...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
